Teva Pharma Industries Ltd ADR (TEVA) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

• Price: $33.77
• Market Cap: $39.16B
• P/E Ratio: 27.79
• EPS: $1.21
• 52-Week High: $37.35
• 52-Week Low: $12.47

Market Sentiment

Teva Pharma Industries Ltd ADR currently has a Bullish sentiment score of 0.29.

About Teva Pharma Industries Ltd ADR

Teva Pharmaceutical Industries Limited (Ticker: TEVA) is a global leader in the development, manufacturing, and distribution of generic and specialty pharmaceuticals, as well as biopharmaceuticals, with a strong presence in North America, Europe, and beyond. Headquartered in Petach Tikva, Israel, Teva's extensive product portfolio addresses a wide range of therapeutic areas, positioning the company as a pivotal player in the pharmaceutical industry. With a commitment to innovation and accessi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Teva Pharma Industries Ltd ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TEVA pay dividends?

Teva Pharma Industries Ltd ADR (TEVA) does not currently pay a regular dividend.

What is TEVA's P/E ratio?

Teva Pharma Industries Ltd ADR has a price-to-earnings (P/E) ratio of 27.79.

What is TEVA's market cap?

Teva Pharma Industries Ltd ADR (TEVA) has a market capitalization of $39.16B with a current stock price of $33.77.